This opportunity is no longer accepting applications.
grant PAR-22-061

Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed)

This grant opportunity is intended to fund basic research exploring how the human microbiome influences anti-tumor immune responses and to find new molecular targets for cancer prevention. Researchers should focus on understanding how interactions between the host and specific microbes or their metabolites affect immune responses related to tumor formation. Applications should thoroughly addre…

The purpose of this Funding Opportunity Announcement (FOA) is to support basic research that elucidates mechanisms by which the human microbiome inhibit or enhance anti-tumor immune responses, and to identify potential novel molecular targets for cancer prevention strategies. Applications should…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Cancer Institute
Program: SBIR

Dates

Opportunity Released: November 3, 2021
Open for Submission: November 3, 2021
Submission Deadline: January 7, 2025
Application Window Closes: January 7, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.